Akili Interactive
Topline data released today by the digital therapeutics company also suggest that its FDA approval-pending treatment continued to deliver benefits with continued use.
Stakeholders at today's DTx East event in Boston discuss digital therapeutic risk assessment and management.
Also: AccuReg brings on a new chief marketing officer; Blink Health hires a tech industry HR vet.
At CES 2019, the digital therapeutic company's CEO and cofounder described work on an independent prescription, procurement and support platform specific to digital medicines.
The study's 19 young participants stuck to their regimens, and along with their parents said that they would be open to continuing treatment sessions.
Also: Greenway Health appoints new CISO; DocuTAP hires SVP of product, EVP of people and culture.